Key facts: Esperion to Delist from Nasdaq; Merger Creates $100M CVRTradingView·Jul 14 at 02:13 AMESPR0.00%
Archimed completes take-private of Esperion in deal valued up to $1.1 billionPUBT·Jul 13 at 08:32 AMESPR0.00%
Esperion Therapeutics Closes Merger; Sets $100M CVR Plan, Amends 2030 Notes, Replaces Credit FacilityTradingView·Jul 13 at 08:13 AMESPR0.00%
Esperion directors Justin Bateman and Ankit Pareek elected as six incumbent directors departTradingView·Jul 13 at 08:13 AMESPR0.00%
Esperion Therapeutics Announced Transfer or Voluntary Withdrawal of ListingTradingView·Jul 13 at 08:13 AMESPR0.00%
Esperion Therapeutics Clears Key Hurdle as Stockholders Approve Essence MergerMarket Beat·Jul 10 at 07:01 AMESPR0.00%
10 Health Care Stocks With Whale Alerts In Today’s Sessionbenzinga_article·Jul 1 at 12:35 PMCRSP+2.37%PURR+4.96%
Esperion cleared for merger by German antitrust authority; stockholder vote set for July 8TradingView·Jun 9 at 03:03 PMESPR0.00%
Esperion Therapeutics’ 10-Q Forward-Looking Statements Highlight Significant Uncertainty and Investor RiskTip Ranks·May 10 at 01:02 AMESPR0.00%
Key facts: Esperion Expands 2024–25 Programs; Estimates Fall 781.6%TradingView·May 9 at 03:03 PMESPR0.00%
